Epelsiban

DB11934InvestigationalSmall molecule

Epelsiban has been investigated for the treatment of Premature Ejaculation.

Chemical structure of Epelsiban
Mechanism
Curator reviewed
Formula / weight
C30H38N4O4 · 518.658 g/mol (avg)
Code names
GSK-557296

Resolves to

Compound
UNIIT2EZ19HX73CAS872599-83-2ChEMBLCHEMBL2037511PubChem11634973
Structure
InChIKeyUWHCWRQFNKUYCG-QUZACWSFSA-NSMILESCC[C@H](C)[C@H]1N([C@@H](C(=O)N2CCOCC2)C2=CC=C(C)N=C2C)C(=O)[C@H](NC1=O)C1CC2=CC=CC=C2C1
Targets
P30559OXTR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Epelsiban, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In